| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.5 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |